Biomarker analysis to predict the pathological response of locally advanced gastric cancer to neoadjuvant chemotherapy: an exploratory study of the randomized phase II COMPASS trial

被引：0
|
作者：
Tanabe, K. [1 ]
Yoshikawa, T. [2 ]
Oshima, T. [3 ]
Miyagi, Y. [4 ]
Morita, S. [5 ]
Nishikawa, K. [6 ]
Ito, Y. [7 ]
Matsui, T. [8 ]
Kimura, Y. [9 ]
Aoyama, T. [2 ]
Hayashi, T. [2 ]
Ogata, T. [2 ]
Cho, H. [2 ]
Tuburaya, A. [10 ]
Sakamoto, J. [11 ]
机构：
[1] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan
[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ Med, Dept Surg, Yokohama, Kanagawa, Japan
[4] Kanagawa Canc Ctr, Res Inst, Mol Pathol & Genet Div, Yokohama, Kanagawa, Japan
[5] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan
[6] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan
[7] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi, Japan
[8] Aichi Hosp, Aichi Canc Ctr, Dept Surg, Okazaki, Aichi, Japan
[9] Sakai City Med Ctr, Dept Surg, Sakai, Osaka, Japan
[10] Yokohama City Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa, Japan
[11] Nagoya Univ, Grad Sch Med, Young Leaders Program, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw363.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
87P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer
    Wang, Xiang
    Zhao, Lin
    Liu, Hongfeng
    Zhong, Dingrong
    Liu, Wei
    Shan, Guangliang
    Dong, Fen
    Gao, Weisheng
    Bai, Chunmei
    Li, Xiaoyi
    BRITISH JOURNAL OF CANCER, 2016, 114 (12) : 1326 - 1333
  • [32] Apatinib plus SOX regimen as neoadjuvant chemotherapy for locally advanced gastric cancer: A phase II study.
    Zheng, Ya'nan
    Yang, Xiao
    Shi, Hongpeng
    Yang, Zhongyin
    Yan, Chao
    Ni, Zhentian
    Li, Mengjiao
    Sah, Birendra Kumar
    Liu, Wentao
    Xu, Wei
    Yao, Xuexin
    Zhu, Zhenglun
    Yan, Min
    Zhu, Zhenggang
    Li, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
    Satake, Hironaga
    Kondo, Masato
    Mizumoto, Motoko
    Kotake, Takeshi
    Okita, Yoshihiro
    Ogata, Takatsugu
    Hatachi, Yukimasa
    Yasui, Hisateru
    Miki, Akira
    Imai, Yukihiro
    Ichikawa, Chihiro
    Murotani, Kenta
    Kotaka, Masahito
    Kato, Takeshi
    Kaihara, Satoshi
    Tsuji, Akihito
    ANTICANCER RESEARCH, 2017, 37 (07) : 3703 - 3710
  • [34] A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer
    Xiang Wang
    Lin Zhao
    Hongfeng Liu
    Dingrong Zhong
    Wei Liu
    Guangliang Shan
    Fen Dong
    Weisheng Gao
    Chunmei Bai
    Xiaoyi Li
    British Journal of Cancer, 2016, 114 : 1326 - 1333
  • [35] Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial
    Wang, Lei
    Sun, Mengting
    Li, Jinyang
    Wan, Linghong
    Tan, Yuting
    Tian, Shuoran
    Hou, Yongying
    Wu, Linyu
    Peng, Ziyi
    Hu, Xiao
    Zhang, Qihua
    Huang, Zening
    Han, Mengyi
    Peng, Shiyin
    Pan, Yuwei
    Ren, Yuanfeng
    Zhang, Mengsi
    Chen, Dongfeng
    Liu, Qin
    Li, Xianfeng
    Qin, Zhong-yi
    Xiang, Junyv
    Li, Mengxia
    Zhu, Jianwu
    Chen, Qiyue
    Luo, Huiyan
    Wang, Shunan
    Wang, Tao
    Li, Fan
    Bian, Xiu-wu
    Wang, Bin
    CLINICAL CANCER RESEARCH, 2025, 31 (01) : 74 - 86
  • [36] The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Qu, Jianjun
    Qu, Xiangyang
    CANCER BIOMARKERS, 2016, 17 (01) : 49 - 54
  • [37] FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
    Yildirim, Emine
    Bektas, Sibel
    Goktas Aydin, Sabin
    Er, Ahmet Muzaffer
    Yanik, Irem
    Gumuskaya, Perihan Ozkan
    Yilmaz, Barbaros Utku
    Bilici, Ahmet
    Oncel, Mustafa
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022, 85 (01): : 41 - 50
  • [38] FACTORS PREDICTING RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER
    Yildirim, Emine
    Bektas, Sibel
    Goktas Aydin, Sabin
    Muzaffer, Ahmet E. R.
    Yanik, Irem
    Gumuskaya, Perihan Ozkan
    Yilmaz, Barbaros Utku
    Bilici, Ahmet
    Oncel, Mustafa
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022,
  • [39] Intratumoral and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer
    Chenchen Liu
    Liming Li
    Xingzhi Chen
    Chencui Huang
    Rui Wang
    Yiyang Liu
    Jianbo Gao
    Insights into Imaging, 15
  • [40] Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy
    Xiaoyuan Gao
    Yang Zhang
    Fei Yuan
    Bei Ding
    Qianchen Ma
    Wenjie Yang
    Jing Yan
    Lianjun Du
    Baisong Wang
    Fuhua Yan
    Martin Sedlmair
    Zilai Pan
    Huan Zhang
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2207 - 2218
12345